GKOS compared with PTCT: revenue, margins and what each company keeps, and the suppliers and customers both name

GKOSGlaukos Corp

Mkt capRevenueRevenue

PTCTPTC Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

GKOSGlaukos Corp

PTCTPTC Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

GKOS

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±14.8%▲+33.65%×2.27

Q2 FY26±14.9%▲+4.24%×0.28

Q1 FY26±10.6%▲+22.84%×2.15

Feb 18 '26±8.2%▲+13.47%×1.65

PTCT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Oct 30 '26±12.0%▼−6.97%×0.58

Q2 FY26±11.6%▼−9.94%×0.85

= impliedGKOS realized, solidPTCT realized, hatchedOne scale, both sides: full bar = 34%× = |realized| ÷ impliedSource: market data

Q1 FY26

±9.4%

▲+14.27%

×1.52

Feb 20 '26±4.3%▲+1.09%×0.26

GKOSGlaukos Corp

238.63▲+0.44%· post 237.00· delayed

Mkt cap$14.1BRevenue$211MQ3 FY26Revenue$507MFY25

PTCTPTC Therapeutics, Inc.

60.97▲+1.67%· post 60.97· delayed

After hoursNov 2 '26delayed

Mkt cap$5.0BRevenue$361MQ2 FY26Revenue$1.7BFY25

Compare

After hoursNov 2 '26delayed

GKOSGlaukos Corp

PTCTPTC Therapeutics, Inc.

238.63▲+0.44%post 237.00delayed

Price

60.97▲+1.67%post 60.97delayed

$14.1B

Mkt cap

$5.0B

Q3 FY26$211M

Revenue

$361MQ2 FY26

FY25$507M

Revenue

$1.7BFY25

GKOS238.63▲+0.44%vsPTCT60.97▲+1.67%After hoursNov 2 '26delayed